vs
Side-by-side financial comparison of AMERICAN PUBLIC EDUCATION INC (APEI) and Axsome Therapeutics, Inc. (AXSM). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $158.3M, roughly 1.2× AMERICAN PUBLIC EDUCATION INC). AMERICAN PUBLIC EDUCATION INC runs the higher net margin — 8.0% vs -14.6%, a 22.5% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -3.5%). AMERICAN PUBLIC EDUCATION INC produced more free cash flow last quarter ($-15.6M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 1.3%).
Strategic Education, Inc. (SEI) is an education services holding company and is formerly known as Strayer Education, Inc. The company owns for-profit, online Capella University and Strayer University, as well as non-degree programs schools such as DevMountain, Hackbright Academy, and Sophia Learning.
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
APEI vs AXSM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $158.3M | $196.0M |
| Net Profit | $12.6M | $-28.6M |
| Gross Margin | 56.4% | — |
| Operating Margin | 12.0% | -13.8% |
| Net Margin | 8.0% | -14.6% |
| Revenue YoY | -3.5% | 65.0% |
| Net Profit YoY | -2.7% | 61.9% |
| EPS (diluted) | $0.67 | $-0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $158.3M | $196.0M | ||
| Q3 25 | $163.2M | $171.0M | ||
| Q2 25 | $162.8M | $150.0M | ||
| Q1 25 | $164.6M | $121.5M | ||
| Q4 24 | $164.1M | $118.8M | ||
| Q3 24 | $153.1M | $104.8M | ||
| Q2 24 | $152.9M | $87.2M | ||
| Q1 24 | $154.4M | $75.0M |
| Q4 25 | $12.6M | $-28.6M | ||
| Q3 25 | $5.6M | $-47.2M | ||
| Q2 25 | $4.5M | $-48.0M | ||
| Q1 25 | $8.9M | $-59.4M | ||
| Q4 24 | $13.0M | $-74.9M | ||
| Q3 24 | $2.3M | $-64.6M | ||
| Q2 24 | $371.0K | $-79.3M | ||
| Q1 24 | $516.0K | $-68.4M |
| Q4 25 | 56.4% | — | ||
| Q3 25 | 54.2% | — | ||
| Q2 25 | 51.8% | — | ||
| Q1 25 | 54.5% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 50.8% | — | ||
| Q2 24 | 50.2% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | 12.0% | -13.8% | ||
| Q3 25 | 5.9% | -27.0% | ||
| Q2 25 | 4.3% | -24.5% | ||
| Q1 25 | 7.4% | -46.9% | ||
| Q4 24 | 13.1% | -61.1% | ||
| Q3 24 | 2.7% | -59.8% | ||
| Q2 24 | 1.5% | -89.5% | ||
| Q1 24 | 3.4% | -89.7% |
| Q4 25 | 8.0% | -14.6% | ||
| Q3 25 | 3.4% | -27.6% | ||
| Q2 25 | 2.8% | -32.0% | ||
| Q1 25 | 5.4% | -48.9% | ||
| Q4 24 | 7.9% | -63.1% | ||
| Q3 24 | 1.5% | -61.7% | ||
| Q2 24 | 0.2% | -91.0% | ||
| Q1 24 | 0.3% | -91.1% |
| Q4 25 | $0.67 | $-0.55 | ||
| Q3 25 | $0.30 | $-0.94 | ||
| Q2 25 | $-0.02 | $-0.97 | ||
| Q1 25 | $0.41 | $-1.22 | ||
| Q4 24 | $0.63 | $-1.54 | ||
| Q3 24 | $0.04 | $-1.34 | ||
| Q2 24 | $-0.06 | $-1.67 | ||
| Q1 24 | $-0.06 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $174.1M | $322.9M |
| Total DebtLower is stronger | $94.7M | — |
| Stockholders' EquityBook value | $294.8M | $88.3M |
| Total Assets | $521.4M | $689.8M |
| Debt / EquityLower = less leverage | 0.32× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $174.1M | $322.9M | ||
| Q3 25 | $191.3M | $325.3M | ||
| Q2 25 | $174.9M | $303.0M | ||
| Q1 25 | $161.6M | $300.9M | ||
| Q4 24 | $131.9M | $315.4M | ||
| Q3 24 | $135.4M | $327.3M | ||
| Q2 24 | $129.8M | $315.7M | ||
| Q1 24 | $125.3M | $331.4M |
| Q4 25 | $94.7M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $94.1M | — | ||
| Q1 25 | $93.7M | — | ||
| Q4 24 | $93.4M | — | ||
| Q3 24 | $93.1M | — | ||
| Q2 24 | $92.8M | — | ||
| Q1 24 | $95.0M | — |
| Q4 25 | $294.8M | $88.3M | ||
| Q3 25 | $279.3M | $73.7M | ||
| Q2 25 | $272.2M | $73.1M | ||
| Q1 25 | $310.0M | $53.2M | ||
| Q4 24 | $303.9M | $57.0M | ||
| Q3 24 | $290.4M | $92.9M | ||
| Q2 24 | $288.7M | $102.9M | ||
| Q1 24 | $288.5M | $144.0M |
| Q4 25 | $521.4M | $689.8M | ||
| Q3 25 | $525.3M | $669.3M | ||
| Q2 25 | $537.4M | $639.8M | ||
| Q1 25 | $578.7M | $596.7M | ||
| Q4 24 | $570.1M | $568.5M | ||
| Q3 24 | $569.6M | $561.5M | ||
| Q2 24 | $560.7M | $548.2M | ||
| Q1 24 | $559.0M | $545.7M |
| Q4 25 | 0.32× | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | 0.33× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.6M | $-18.7M |
| Free Cash FlowOCF − Capex | $-15.6M | $-18.7M |
| FCF MarginFCF / Revenue | -9.9% | -9.6% |
| Capex IntensityCapex / Revenue | 2.6% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.92× | — |
| TTM Free Cash FlowTrailing 4 quarters | $46.1M | $-93.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.6M | $-18.7M | ||
| Q3 25 | $21.7M | $1.0M | ||
| Q2 25 | $14.8M | $-32.4M | ||
| Q1 25 | $37.0M | $-43.4M | ||
| Q4 24 | $1.6M | $-26.2M | ||
| Q3 24 | $14.1M | $-18.6M | ||
| Q2 24 | $12.5M | $-30.1M | ||
| Q1 24 | $20.7M | $-53.5M |
| Q4 25 | $-15.6M | $-18.7M | ||
| Q3 25 | $17.5M | $988.0K | ||
| Q2 25 | $11.1M | $-32.4M | ||
| Q1 25 | $33.1M | $-43.7M | ||
| Q4 24 | $-1.8M | $-26.2M | ||
| Q3 24 | $7.8M | $-18.7M | ||
| Q2 24 | $7.3M | $-30.2M | ||
| Q1 24 | $14.5M | $-53.6M |
| Q4 25 | -9.9% | -9.6% | ||
| Q3 25 | 10.7% | 0.6% | ||
| Q2 25 | 6.8% | -21.6% | ||
| Q1 25 | 20.1% | -36.0% | ||
| Q4 24 | -1.1% | -22.1% | ||
| Q3 24 | 5.1% | -17.9% | ||
| Q2 24 | 4.7% | -34.6% | ||
| Q1 24 | 9.4% | -71.4% |
| Q4 25 | 2.6% | 0.0% | ||
| Q3 25 | 2.6% | 0.0% | ||
| Q2 25 | 2.3% | 0.0% | ||
| Q1 25 | 2.4% | 0.3% | ||
| Q4 24 | 2.0% | 0.0% | ||
| Q3 24 | 4.1% | 0.1% | ||
| Q2 24 | 3.4% | 0.1% | ||
| Q1 24 | 4.0% | 0.1% |
| Q4 25 | -0.92× | — | ||
| Q3 25 | 3.90× | — | ||
| Q2 25 | 3.29× | — | ||
| Q1 25 | 4.16× | — | ||
| Q4 24 | 0.12× | — | ||
| Q3 24 | 6.22× | — | ||
| Q2 24 | 33.57× | — | ||
| Q1 24 | 40.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APEI
| American Public Education Inc Segment | $71.0M | 45% |
| Rasmussen University Segment | $66.6M | 42% |
| Hondros College Of Nursing Segment | $20.7M | 13% |
AXSM
Segment breakdown not available.
